M
Maarten L. Simoons
Researcher at Erasmus University Rotterdam
Publications - 416
Citations - 56017
Maarten L. Simoons is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 90, co-authored 415 publications receiving 54201 citations. Previous affiliations of Maarten L. Simoons include University of Arizona & University of Massachusetts Medical School.
Papers
More filters
Journal ArticleDOI
Third universal definition of myocardial infarction
Kristian Thygesen,Joseph S. Alpert,Allan S. Jaffe,Maarten L. Simoons,Bernard R. Chaitman,Harvey D. White +5 more
TL;DR: Information on MI rates can provide useful information regarding the burden of CAD within and across populations, especially if standardized data are collected in a manner that …
Journal ArticleDOI
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
Elliott M. Antman,Jean-Pierre Bassand,Werner Klein,Magnus Ohman,José Luis López Sendón,Lars Rydén,Maarten L. Simoons,Michal Tendera +7 more
TL;DR: In this paper, the authors defined the definition of MI and established the following criteria for acute, evolving or recent MI: 1) Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a) ischemic symptoms; b) development of pathologic Qwaves on the ECG; c) ECG changes indicative of ischemia (ST segment elevation or depression); or d) coronary artery intervention (e.g., coronary ang
Journal ArticleDOI
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot,Udo Sechtem,Stephan Achenbach,Felicita Andreotti,Chris Arden,Andrzej Budaj,Raffaele Bugiardini,Filippo Crea,Thomas Cuisset,Carlo Di Mario,J. Rafael Ferreira,Bernard J. Gersh,Anselm K. Gitt,Jean-Sébastien Hulot,Nikolaus Marx,Lionel H. Opie,Matthias Pfisterer,Eva Prescott,Frank Ruschitzka,Manel Sabaté,Roxy Senior,David P. Taggart,Ernst E. van der Wall,Christiaan J. Vrints,José Luis Zamorano,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Veronica Dean,Christi Deaton,Çetin Erol,Robert Fagard,Roberto Ferrari,David Hasdai,Arno W. Hoes,Paulus Kirchhof,Juhani Knuuti,Philippe Kolh,Patrizio Lancellotti,Aleš Linhart,Petros Nihoyannopoulos,Massimo F Piepoli,Piotr Ponikowski,Per Anton Sirnes,Juan Tamargo,Michal Tendera,Adam Torbicki,William Wijns,Stephan Windecker,Marco Valgimigli,Marc J. Claeys,Norbert Donner-Banzhoff,Herbert Frank,Christian Funck-Brentano,Oliver Gaemperli,José Ramón González-Juanatey,Michalis Hamilos,Steen Husted,Stefan James,Kari Kervinen,Steen Dalby Kristensen,Aldo P. Maggioni,Axel R. Pries,Francesco Romeo,Lars Rydén,Maarten L. Simoons,Ph. Gabriel Steg,Adam Timmis,Aylin Yildirir +68 more
TL;DR: The If Inhibitor Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Dysfunction is evaluated as well as patients with Diabetes mellitus for Optimal management of Multivessel disease.
Journal ArticleDOI
Universal definition of myocardial infarction.
Kristian Thygesen,Joseph S. Alpert,Harvey D. White,Allan S. Jaffe,Fred S. Apple,Marcello Galvani,Hugo A. Katus,L. Kristin Newby,Jan Ravkilde,Bernard R. Chaitman,Peter Clemmensen,Mikael Dellborg,Hanoch Hod,Pekka Porela,Richard Underwood,Jeroen J. Bax,George A. Beller,Robert O. Bonow,Ernst E. van der Wall,Jean-Pierre Bassand,William Wijns,T. Bruce Ferguson,Philippe Gabriel Steg,Barry F. Uretsky,David O. Williams,Paul W. Armstrong,Elliott M. Antman,Keith A.A. Fox,Christian W. Hamm,E. Magnus Ohman,Maarten L. Simoons,Philip A. Poole-Wilson,Enrique P. Gurfinkel,José-Luis López-Sendón,Prem Pais,Shanti Mendis,Jun-Ren Zhu,Lars Wallentin,Francisco Fernández-Avilés,Kim Fox,Alexander Parkhomenko,Silvia G. Priori,Michal Tendera,Liisa-Maria Voipio-Pulkki,Alec Vahanian,A. John Camm,Raffaele De Caterina,Veronica Dean,Kenneth Dickstein,Gerasimos Filippatos,Christian Funck-Brentano,Irene Hellemans,Steen Dalby Kristensen,Keith McGregor,Udo Sechtem,Sigmund Silber,Petr Widimsky,José Luis Zamorano,João Morais,Sorin J. Brener,Robert A. Harrington,David A. Morrow,Michael J. Lim,Marco A. Martinez-Rios,Steve Steinhubl,Glen N. Levine,W. Brian Gibler,David C. Goff,Marco Tubaro,Darek Dudek,Nawwar Al-Attar +70 more
TL;DR: Information on myocardial infarction attack rates can provide useful data regarding the burden of coronary artery disease within and across populations, especially if standardized data are collected in a manner that demonstrates the distinction between incident and recurrent events.
Journal ArticleDOI
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
Guy De Backer,Ettore Ambrosioni,Knut Borch-Johnsen,Carlos Brotons,Renata Cifkova,Jean Dallongeville,Shah Ebrahim,Ole Faergeman,Ian D. Graham,Giuseppe Mancia,Volkert Manger Cats,Kristina Orth-Gomér,Joep Perk,Kalevi Pyörälä,Jose L. Rodicio,Susana Sans,Vedat Sansoy,Udo Sechtem,Sigmund Silber,Troels Thomsen,David R. Wood,Christian Albus,Nuri Bages,Gunilla Burell,Ronan M. Conroy,Hans Christian Deter,Christoph Hermann-Lingen,Steven Humphries,Anthony Fitzgerald,Brian Oldenburg,Neil Schneiderman,Antti Uutela,Redford Williams,John Yarnell,Silvia G. Priori,Maria Angeles Alonso Garcia,Jean-Jacques Blanc,Andrzej Budaj,Martin R. Cowie,Veronica Dean,Jaap W. Deckers,Enrique Fernandez Burgos,John Lekakis,Bertil Lindahl,Gianfranco Mazzotta,Keith McGregor,João Morais,Ali Oto,Otto A. Smiseth,Hans-Joachim Trappe,Carl-David Agardh,Jean-Pierre Bassand,Maciek Godycki-Cwirko,Anthony M. Heagerty,Robert J. Heine,Philip Home,Silvia Priori,Pekka Puska,Mike Rayner,Annika Rosengren,Mario Sammut,James Shepherd,Johannes Siegrist,Maarten L. Simoons,Michal Tendera,Alberto Zanchetti +65 more
TL;DR: It is of great importance that guidelines and recommendations are presented in formats that are easily interpreted, and their implementation programmes must also be well conducted.